The Hindu Business Line : JB Chemicals to set up unit for `Doktor Mom'

J B Chemicals and Pharmaceuticals Ltd has announced plans to set up a unit to manufacture its `Doktor Mom' brand of cough lozenges and tablets in Daman.

The unit will be built as per international GMP standards at a projected cost of Rs 15 crore to be financed completely through internal accruals. The project is expected to go on stream by year 2003, Mr J.B. Mody, Chairman, told shareholders at the company's annual general meeting recently.

Profits from this new facility would be completely tax-free for the first five years. JBCPL's Doktor Mom was also adjudged the `Most trusted European brand' in 2001-02, a news release said.

Shareholders of the company also approved a final dividend of 50 per cent including a jubilee dividend of 15 per cent. The total dividend payout for the financial year 2001-02 is 75 per cent as the company had already paid 25 per cent interim dividend, the release said.

Total dividend payout for the year would be Rs 12.45 crore, 41 per cent higher than last year.

JBPCL has set up a target of reaching a turnover of Rs 500 crore by 2005. To meet the target, the company has been increasingly focusing on research and development.

So far, JBPCL has discovered 20 new molecules in various therapeutic segments and filed applications in the US, South Africa and other countries for patenting these molecules.

During the year, the company has also applied for EP4 certification to European Directorate for Quality of Medicines for its other two APIs - - Metronidazole and Diclofenac Sodium, to consolidate its position in the European markets.

The company reported 16 per cent increase in turnover at Rs 276.02 crore and a 34.56 per cent jump in net profit at Rs 42.05 crore for the financial year 2001-02.

Send this article to Friends by E-Mail

Stories in this Section
Ranbaxy files application for IV form of Ranbezolid

Amadeus firms up plan to raise market share

Oriental Hotels to pay 45 pc

Apollo Hospitals launches package for diabetics

Can President Bush afford to talk tough?

Dabur moves a step towards demerger — Separates pharma, FMCG businesses

`Corporate governance ratings can curb frauds'

DCA Secy seeks changes in Companies Act

Raunaq Plastics sets up facility near Kolkata

JB Chemicals to set up unit for `Doktor Mom'

Samir Biswas takes over at DCA

Kores India ties up with Brother Intl

Electrolux rights issue runs into rough weather — Company mulling other plans

Lakshmi Synthetic looking down the barrel

LML hopes Freedom will drive it into the black

West Coast Paper plans growth thru acquisitions

Kinetic Intl to be formed in two months

LG Elec registers 42 pc rise in turnover in H1